[Federal Register Volume 62, Number 81 (Monday, April 28, 1997)]
[Notices]
[Page 22950]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-10908]
[[Page 22950]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Findings of Scientific Misconduct
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the Office of Research Integrity
(ORI) has made a final finding of scientific misconduct in the
following case:
Weidong Sun, M.D., Ph.D., Medical College of Pennsylvania and
Hahnemann University: Based upon a report forwarded to the Office of
Research Integrity (ORI) by the Medical College of Pennsylvania and
Hahnemann University as well as information obtained by ORI during its
oversight review, ORI found that Dr. Sun, a former graduate student in
the Department of Physiology, Medical College of Pennsylvania and
Hahnemann University, engaged in scientific misconduct by falsifying
data in conducting and reporting research supported by a grant from the
National Institute of Arthritis and Musculoskeletal and Skin Diseases
(NIAMS), National Institutes of Health (NIH). The research also was
reported in applications requesting funding from NIAMS and the National
Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH.
Specifically, Dr. Sun falsified data by misrepresenting cloned DNA
sequences from chicken non-muscle myosin as an isoform of neuronal
myosin II from rat brain. The falsified cDNA was included in the
following publications and nucleotide sequences in GenBank and EMBL
databases:
Sun, W.D., & Chantler, P.D. ``Cloning of the cDNA encoding
a neuronal myosin heavy chain from mammalian brand and its differential
expression within the central nervous system.'' Journal of Molecular
Biology 224(4):1185-1193, 1992;
Sun, W.D., & Chantler, P.D. ``A unique cellular myosin II
exhibiting differential expression in the cerebral cortex.''
Biochemical and Biophysical Research Communications 175(1):244-249,
1991;
Sun, W., Chen, X., & Chantler, P.D. ``Inhibition of
neuritogenesis by antisense arrest of the expression of a specific
isoform of brain myosin II.'' Journal of Muscle Research and Cell
Motility 15:184-185, 1994;
M64596, ``Rat myosin II mRNA, 3' end.'' [RETMYOSII];
M80591, ``Rat neuronal myosin heavy chain mRNA, 3' end.''
[RATMYOH3E];
M94962, ``Rattus rattus neuronal myosin heavy chain gene
promoter sequence.'' [RATMYOPRO]; and
X62659, S98128, ``R.rattus MRNA for brain neuronal myosin
heavy chain.'' [RRNMYOHC].
Retractions of the publications and deletions from the public data
banks have been requested.
Dr. Sun has accepted the ORI finding and has entered into a
Voluntary Exclusion Agreement with ORI in which he has voluntarily
agreed, for the three (3) year period beginning April 17, 1997:
(1) To exclude himself from any contracting or subcontracting with
any agency of the United States Government and from eligibility for, or
involvement in, nonprocurement transactions (e.g., grants and
cooperative agreements) of the United States Government as defined in
45 CFR part 76 (Debarment Regulations); and
(2) To exclude himself from serving in any advisory capacity to the
Public Health Service (PHS), including but not limited to service on
any PHS advisory committee, board, and/or peer review committee, or as
a consultant.
FOR FURTHER INFORMATION CONTACT: Acting Director, Division of Research
Investigations, Office of Research Integrity, 5515 Security Lane, Suite
700, Rockville, MD 20852, (301) 443-5330.
Chris B. Pascal,
Acting Director, Office of Research Integrity.
[FR Doc. 97-10908 Filed 4-25-97; 8:45 am]
BILLING CODE 4160-17-P
